论坛 › 天涯情感 › 5年存活率高达91.9%！中晚期结直肠癌亦可实现手术切除，得到临床治愈

fny5jt9 发表于 2024-6-24 18:07:02

5年存活率高达91.9%！中晚期结直肠癌亦可实现手术切除，得到临床治愈

    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/mmbiz_gif/laxhFHE1XFcJQzh9fqoqb7dYYXNLqOqV6icjlgOKJJEzNZ7jM2kUgO9ic3jZJUZuL1eTTKk7TgoePCfe467EfbLw/640?wx_fmt=gifwxfrom=5wx_lazy=1&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1" style="width: 50%; margin-bottom: 20px;"></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">中国中晚期结直肠癌<span style="color: black;">病人</span>诊疗<span style="color: black;">状况</span>调查结果指出，约83%的结直肠癌<span style="color: black;">病人</span>确诊时<span style="color: black;">已然</span>发展至中晚期，44%的<span style="color: black;">病人</span><span style="color: black;">出现</span>了肝、肺等部位的转移。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">非常多</span>人认为结直肠癌<span style="color: black;">发展</span>到中晚期，<span style="color: black;">已然</span>失去了手术临床治愈的机会，但其实，<strong style="color: blue;">即使是中晚期、<span style="color: black;">已然</span><span style="color: black;">出现</span>转移的结直肠癌，仍然有机会实现手术切除，<span style="color: black;">得到</span>临床治愈</strong>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/mmbiz_png/laxhFHE1XFfbYAZ9icjCO4oV1NqvoprNUHH01dVGa4qYqZuPTBg0bmnBgJqksdp9L3xPdaege8xJOeoexL21icGg/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" style="width: 50%; margin-bottom: 20px;"></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">▲图源：</span><span style="color: black;">创客贴</span></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;">中晚期结直肠癌<span style="color: black;">存活</span>率高达91.9%</strong></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">众所周知，手术是结直肠癌治疗的金标准，能否手术<span style="color: black;">针对</span>结直肠癌<span style="color: black;">病人</span>的预后<span style="color: black;">拥有</span><span style="color: black;">要紧</span>影响。<span style="color: black;">即时</span>有效的手术治疗，能够在<span style="color: black;">加强</span><span style="color: black;">存活</span>率的<span style="color: black;">同期</span>，降低术后并发症<span style="color: black;">出现</span>率。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;">III期结直肠癌术后5年<span style="color: black;">存活</span>率<span style="color: black;">达到</span>92.5%</strong></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">按照</span>《日本结肠直肠癌协会 (JSCCR) 2019 年结直肠癌治疗指南》中的数据<span style="color: black;">表示</span>，<span style="color: black;"><strong style="color: blue;">III期结直肠癌采用手术切除的效果<span style="color: black;">明显</span>，IIIA期5年<span style="color: black;">存活</span>率高达91.9%，IIIB期5年<span style="color: black;">存活</span>率达到81.8%</strong></span>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">且肿瘤浸润部位，5年<span style="color: black;">存活</span>率不同：</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;">结肠：</strong>IIIA期5年<span style="color: black;">存活</span>率为92.4%，IIIB期5年<span style="color: black;">存活</span>率为83.6%；</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;">直肠乙状结肠：</strong>IIIA期5年<span style="color: black;">存活</span>率为92.5%，IIIB期5年<span style="color: black;">存活</span>率为80.2%；</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;">直肠上部和下部：</strong>IIIA期5年<span style="color: black;">存活</span>率为90.9%，IIIB期5年<span style="color: black;">存活</span>率为80.5%；</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;">肛管：</strong>IIIA期5年<span style="color: black;">存活</span>率为78.6%，IIIB期5年<span style="color: black;">存活</span>率为61.5%。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/mmbiz_png/laxhFHE1XFdF69Ne0WHtDZaeEPjkJypBzNQoL61WhRicB2rgZLL5Mb5HnLFACJ3UnzNgLMyxXoB1v0g7vKHqEWg/640?wx_fmt=png&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" style="width: 50%; margin-bottom: 20px;"></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">▲不同病理分期的结直肠癌<span style="color: black;">病人</span>的术后5年<span style="color: black;">存活</span>率，图源：参考<span style="color: black;">源自</span></span></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;">转移性结直肠癌5年<span style="color: black;">存活</span>率高达60%</strong></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">肝脏是结直肠癌<span style="color: black;">平常</span>的转移部位。<span style="color: black;">针对</span>结直肠癌肝转移，<span style="color: black;">海量</span>的临床<span style="color: black;">实验</span><span style="color: black;">已然</span>证实，采用手术切除肝脏病灶<span style="color: black;">能够</span><span style="color: black;">得到</span>良好的预后。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">早在2016年<span style="color: black;">发布</span>的<span style="color: black;">相关</span>“结直肠癌手术的效果和复发率”的综述中的数据<span style="color: black;">表示</span>，<span style="color: black;"><strong style="color: blue;">肝转移病灶完全切除的结直肠癌<span style="color: black;">病人</span>5年<span style="color: black;">存活</span>率高达60%</strong></span>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/mmbiz_png/laxhFHE1XFdF69Ne0WHtDZaeEPjkJypBYcE281AlmX1mcUcMe1vZ0uQGE7ibtRiaGpcH3MBiciaBdXyApaOeAlHHDg/640?wx_fmt=png&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" style="width: 50%; margin-bottom: 20px;"></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">▲图源：参考<span style="color: black;">源自</span></span></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">亦</span><span style="color: black;">便是</span>说，<span style="color: black;"><strong style="color: blue;">只要把握住手术的<span style="color: black;">机会</span>，中晚期结直肠癌<span style="color: black;">亦</span>是<span style="color: black;">能够</span><span style="color: black;">得到</span>临床治愈的！</strong></span></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;"><span style="color: black;">怎样</span><span style="color: black;">加强</span>结直肠癌手术治疗的效果？</strong></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">相比<span style="color: black;">初期</span>结直肠癌，中晚期结直肠癌手术治疗难度<span style="color: black;">很强</span>、复发转移的概率较高。<span style="color: black;">因此呢</span><strong style="color: blue;"><span style="color: black;">针对</span>中晚期结直肠癌的手术，<span style="color: black;">能够</span><span style="color: black;">经过</span>围手术期治疗、微创手术以及<span style="color: black;">选取</span>权威的外科<span style="color: black;">大夫</span>来<span style="color: black;">加强</span>预后效果</strong>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;">围手术期治疗必不可少</strong></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">围手术期治疗<span style="color: black;">包含</span>转化治疗、术前新辅助治疗以及术后辅助治疗，<span style="color: black;">能够</span><span style="color: black;">加强</span>结直肠癌患者手术治疗的切除率、改善预后、延长<span style="color: black;">存活</span>期。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">1</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">转化治疗</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">转化治疗是一种<span style="color: black;">经过</span>对适合<span style="color: black;">病人</span>进行术前系统或局部治疗，使肿瘤缩小，<span style="color: black;">从而</span>将初始不可切除病灶转化为可手术切除病灶的治疗<span style="color: black;">办法</span>。多项<span style="color: black;">科研</span><span style="color: black;">显示</span>，<span style="color: black;">经过</span>采用术前<span style="color: black;">药品</span>治疗<span style="color: black;">能够</span>将初始不可切除的晚期结直肠癌<span style="color: black;">病人</span>转变为可切除，<span style="color: black;">针对</span><span style="color: black;">加强</span><span style="color: black;">病人</span>的手术切除率，<span style="color: black;">加强</span><span style="color: black;">存活</span>期<span style="color: black;">拥有</span><span style="color: black;">要紧</span>意义。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">2004年<span style="color: black;">发布</span>在《临床肿瘤学杂志（Journal of Clinical Oncology）》的<span style="color: black;">科研</span><span style="color: black;">已然</span>证实，<strong style="color: blue;">FOLFIRI（氟尿嘧啶+伊立替康）、FOLFOX（氟尿嘧啶+奥沙利铂）传统化疗<span style="color: black;">方法</span>能够实现9%-22%的转化率</strong>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">2</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">新辅助治疗</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">新辅助治疗可使肿瘤降期、肿瘤体积缩小、肿瘤活性降低以利于手术切除，<span style="color: black;">加强</span>手术R0切除率和病理完全缓解（pCR）率，<span style="color: black;">同期</span>术前治疗还可消灭其他部位的潜在微小转移灶，从而<span style="color: black;">加强</span>局部<span style="color: black;">掌控</span>率和总<span style="color: black;">存活</span>率。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">2020年由日本顺天堂大学<span style="color: black;">附庸</span>顺天堂医院消化外科杉本起一教授参与并<span style="color: black;">发布</span>的一项临床<span style="color: black;">实验</span>针对局部晚期直肠癌进行术前放化疗或化疗的效果进行了<span style="color: black;">评定</span>。<span style="color: black;">科研</span>结果<span style="color: black;">表示</span>，<strong style="color: blue;">术前采用放化疗的局部晚期结直肠癌病理缓解率要高于仅采用化疗的<span style="color: black;">病人</span>，证实了术前放化疗在直肠癌治疗<span style="color: black;">行业</span>的有效性</strong>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">3</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">辅助治疗</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">术后辅助治疗即针对复发高危<span style="color: black;">原因</span>，可消灭<span style="color: black;">身体</span>残余的癌细胞，以降低肿瘤复发或向其他部位播散的可能性，从而延长<span style="color: black;">病人</span><span style="color: black;">存活</span>期。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">此前的<span style="color: black;">科研</span>证实，<strong style="color: blue;">辅助化疗的益处在Ⅲ期(淋巴结阳性)结肠癌<span style="color: black;">病人</span>中更为<span style="color: black;">知道</span>，可将复发<span style="color: black;">危害</span>相对下降约30%，死亡率相对下降22%-32%，其已<span style="color: black;">作为</span>此类<span style="color: black;">病人</span>的标准治疗</strong>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;">微创手术的<span style="color: black;">恰当</span>应用</strong></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">近年来，腹腔镜手术、达芬奇<span style="color: black;">设备</span>人手术等微创手术的应用，为结直肠癌<span style="color: black;">病人</span>带来了新的转机。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">但在人们的印象中，腹腔镜手术等微创技术只能应用于<span style="color: black;">初期</span>结直肠癌，但<span style="color: black;">针对</span><span style="color: black;">有些</span>中期结直肠癌<span style="color: black;">病人</span>及<span style="color: black;">出现</span>肝、肺等部位转移的结直肠癌<span style="color: black;">病人</span>仍然<span style="color: black;">能够</span>应用微创手术<span style="color: black;">加强</span>预后效果。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">1</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">日本一项随机对照<span style="color: black;">科研</span><span style="color: black;">显示</span>，<span style="color: black;">经过</span>腹腔镜手术对Ⅱ期或Ⅲ期结肠癌<span style="color: black;">病人</span>进行完整结肠系膜切除(complete mesocolic excision，CME)及D3淋巴结清扫的<span style="color: black;">长时间</span>效果值得肯定，<strong style="color: blue;">术后5年<span style="color: black;">存活</span>率为91.8%</strong>，与开腹手术(90.4%)相比<span style="color: black;">没</span>明显差异。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">2</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">2021年<span style="color: black;">发布</span>的一项<span style="color: black;">科研</span>针对腹腔镜手术和开腹手术治疗结直肠癌肝转移<span style="color: black;">病人</span>的效果进行了分析，<span style="color: black;">科研</span>结果<span style="color: black;">表示</span>，<strong style="color: blue;">腹腔镜手术与开腹手术相比，<span style="color: black;">表示</span>出<span style="color: black;">类似</span>的3年总<span style="color: black;">存活</span>率</strong>（74.4% vs. 74.2%），<strong style="color: blue;">3年<span style="color: black;">没</span>病<span style="color: black;">存活</span>率更高</strong>（57.8% vs. 47.4%），且<strong style="color: blue;">住院时间<span style="color: black;">明显</span>减少、并发症<span style="color: black;">出现</span>率相对更低</strong>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">必须</span><span style="color: black;">重视</span>的是，<strong style="color: blue;">手术<span style="color: black;">方法</span>的<span style="color: black;">选取</span><span style="color: black;">不仅</span>是<span style="color: black;">按照</span>结直肠癌的位置和临床分期，还<span style="color: black;">必须</span><span style="color: black;">按照</span>肿瘤的体积、侵犯程度、<span style="color: black;">是不是</span><span style="color: black;">显现</span>淋巴血管的侵犯、<span style="color: black;">是不是</span><span style="color: black;">显现</span>远处转移等来<span style="color: black;">仔细</span>判断</strong>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">不同病情，<span style="color: black;">选取</span>的手术方式<span style="color: black;">亦</span>不相同</strong></span>。<span style="color: black;">因此呢</span>，<strong style="color: blue;">能否采用微创手术进行治疗，还<span style="color: black;">必须</span>由专业权威的<span style="color: black;">大夫</span>，<span style="color: black;">按照</span>结直肠癌<span style="color: black;">病人</span>的病情判断</strong>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;"><span style="color: black;">选取</span>权威的主刀<span style="color: black;">大夫</span></strong></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;">能力强、水平高、经验丰富的主刀<span style="color: black;">大夫</span>能更准确地为<span style="color: black;">病人</span>制定手术治疗<span style="color: black;">方法</span>，<span style="color: black;">加强</span>结直肠癌<span style="color: black;">病人</span>手术治疗的效果，减少并发症，使<span style="color: black;">病人</span>在术后得以<span style="color: black;">持有</span>高质量的生活</strong>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">因此呢</span>，确诊结直肠癌的<span style="color: black;">病人</span><span style="color: black;">选取</span>权威的外科专家进行诊治<span style="color: black;">非常</span><span style="color: black;">重要</span>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">日本顺天堂大学<span style="color: black;">附庸</span>顺天堂医院<span style="color: black;">做为</span>日本综合排名一位的医院</strong></span>，在结直肠癌的治疗<span style="color: black;">行业</span><span style="color: black;">亦</span>经验丰富，其<span style="color: black;"><strong style="color: blue;">大肠·肛门外科是日本历史悠久的胃肠外科之一，<span style="color: black;">亦</span>是率先引入结直肠癌微创手术的医院</strong></span>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">顺天堂医院大肠·肛门外科<span style="color: black;">持有</span>日本权威的、临床治疗经验丰富的结直肠癌外科治疗专家和先进的微创手术技术，<span style="color: black;">能够</span>为结直肠癌<span style="color: black;">病人</span><span style="color: black;">供给</span>个体化、<span style="color: black;">精细</span>化的治疗<span style="color: black;">方法</span>。<strong style="color: blue;">即使是<span style="color: black;">有些</span>其他医院认为<span style="color: black;">没</span>法手术治疗的<span style="color: black;">病人</span>，在顺天堂医院<span style="color: black;">亦</span>可能<span style="color: black;">得到</span>手术机会</strong>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">尤其是<span style="color: black;"><strong style="color: blue;">顺天堂医院大肠·肛门外科的杉本起一教授是日本权威的结直肠癌外科治疗专家</strong></span>，在结直肠癌治疗<span style="color: black;">行业</span><span style="color: black;">拥有</span>丰富的临床经验和极高的专业水平，曾<span style="color: black;">得到</span>2022年顺天堂大学医学部同窗会学术奖励奖、2020年日本胃癌学会学会奖（西纪念奖）等奖项，还曾参与《普通消化外科手术》杂志的“巅峰”——《手术》的编撰。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">杉本起一教授深耕结直肠癌的综合性、个体化治疗，他进行的“<span style="color: black;">运用</span>DNA甲基化分析的大肠癌个体化治疗治疗的可能性”的<span style="color: black;">科研</span>荣获2022年获顺天堂大学医学部同窗会学术奖励奖，有望实现大肠癌<span style="color: black;">病人</span>的预后分层和个体化医疗。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/mmbiz_png/laxhFHE1XFdF69Ne0WHtDZaeEPjkJypBOyqMJhAOzacQWNMIo0bibrE20XcP2OeWiaahVHZKSYSia35YTx97FWxag/640?wx_fmt=png&amp;from=appmsg&amp;tp=webp&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" style="width: 50%; margin-bottom: 20px;"></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">▲图源：日本顺天堂大学<span style="color: black;">附庸</span>顺天堂医院</span></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">厚朴方舟<span style="color: black;">做为</span>国内知名海外医疗服务<span style="color: black;">公司</span>，<span style="color: black;">能够</span>为<span style="color: black;">病人</span>预约日本顺天堂大学<span style="color: black;">附庸</span>顺天堂医院的杉本起一教授在内的权威专家诊治，<span style="color: black;">加强</span>结直肠癌<span style="color: black;">病人</span>的预后。如<span style="color: black;">期盼</span><span style="color: black;">认识</span><span style="color: black;">更加多</span>结直肠癌治疗的内容，或有意向预约杉本起一教授诊治的，<span style="color: black;">能够</span>拔打热线<span style="color: black;"><strong style="color: blue;">400-081-6600</strong></span>或添加<span style="color: black;">微X</span><span style="color: black;"><strong style="color: blue;">DrHopeNoah</strong></span>联系<span style="color: black;">咱们</span>。</p><img src="https://mmbiz.qpic.cn/mmbiz_gif/laxhFHE1XFfxyOQHUyRdsV58BrhCCQmSggk1L21a27Zr4CFTjzEUs1gI4DrxKUWyK1w5rfEtT0SII7PYRhSBkA/640?wx_fmt=gif&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;tp=webp" style="width: 50%; margin-bottom: 20px;">
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">健康所系，性命相托，厚朴方舟愿用<span style="color: black;">优秀</span>的医疗服务，<span style="color: black;">作为</span>您心中的诺亚方舟。厚朴方舟2012年进入海外医疗<span style="color: black;">行业</span>，<span style="color: black;">日前</span>已<span style="color: black;">作为</span>国内知名海外医疗服务<span style="color: black;">公司</span>，<strong style="color: blue;"><span style="color: black;">持有</span>来自<span style="color: black;">全世界</span>多个国家并经过严格筛选的权威<span style="color: black;">大夫</span>团队，<span style="color: black;">长时间</span>密切合作的医院多达百余家</strong>。</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/mmbiz_png/laxhFHE1XFdNnJ8YicOm5y5ibjwBvdtqia7jtPTMACe0syc7GQbfoXibP5jicKIBL7Rb8DXkfxNVOrWpvDFeDz49SZQ/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" style="width: 50%; margin-bottom: 20px;"></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">数年</span>来，肩负<strong style="color: blue;"><span style="color: black;">“只为更好医疗”</span></strong>的使命，厚朴方舟利用<span style="color: black;">优秀</span>的国际医疗资源，<strong style="color: blue;"><span style="color: black;">按照</span><span style="color: black;">病人</span>病情快速匹配适合的<span style="color: black;">大夫</span>医院，规划更<span style="color: black;">恰当</span>的<span style="color: black;">看病</span><span style="color: black;">方法</span>，快速预约权威专家远程会诊咨询、短时间内抵达海外<span style="color: black;">看病</span></strong>等，为数以万计的<span style="color: black;">病人</span>和家庭<span style="color: black;">供给</span>了<strong style="color: blue;"><span style="color: black;">“更好、更快、更省”</span></strong>的<span style="color: black;">优秀</span>海外医疗服务！</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">往期精彩回顾</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">1</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><a style="color: black;"><span style="color: black;">警觉</span>！这种<span style="color: black;">食品</span>会让大脑“上瘾”，千万别贪吃</a></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">2</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><a style="color: black;"><span style="color: black;">不易</span><span style="color: black;">病患</span>癌症的人，<span style="color: black;">通常</span>都有这7个特征！快来<span style="color: black;">瞧瞧</span>你占了几个？</a></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">3</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><a style="color: black;">【厚朴案例】耄耋之年确诊<span style="color: black;">没</span>手术指征小细胞肺癌，日本<span style="color: black;">呼气</span>科教授却认为应以临床治愈为<span style="color: black;">目的</span></a></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">版权声明：本文为厚朴方舟原创内容，版权归厚朴方舟所有，欢迎转发<span style="color: black;">伴侣</span>圈，任何公众号或其他<span style="color: black;">媒介</span>转载<span style="color: black;">必要</span>注明<span style="color: black;">源自</span>于【厚朴方舟】（ID：hope-noah）<span style="color: black;">或</span>后台联系<span style="color: black;">博主</span>开白名单。</span></p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">参考<span style="color: black;">源自</span>：</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020 Jan;25(1):1-42. doi: 10.1007/s10147-019-01485-z. Epub 2019 Jun 15. PMID: 31203527; PMCID: PMC6946738.</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">Recurrence after hepatic resection in colorectal cancer liver metastasis -Review article-</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564049/</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">&nbsp;Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004 Jan 15;22(2):229-37. doi: 10.1200/JCO.2004.05.113. Epub 2003 Dec 2. PMID: 14657227.</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">局所進行直腸癌(LARC)における術前化学療法の検討</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">http://archive.jsco.or.jp/detail.php?sess_id=17131</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">Adjuvant therapy for resected stage II colon cancer - UpToDate</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">https://www.uptodate.com/contents/adjuvant-therapy-for-resected-stage-ii-colon-cancer</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">&nbsp;KitanoS, InomataM, MizusawaJ, et al. Survival outcomes following laparoscopic versus open d3 dissection for stage ii or iii colon cancer (jcog0404): A phase 3, randomised controlled trial . Lancet Gastroentero Hepatol, 2017, 2(4): 261-268.</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">Frontiers | One-Stage Total Laparoscopic Treatment for Colorectal Cancer With Synchronous Metastasis. Is It Safe and Feasible? | Surgery</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">https://www.frontiersin.org/articles/10.3389/fsurg.2021.752135/full</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">大腸・肛門外科｜スタッフ紹介｜順天堂大学医学部<span style="color: black;">附庸</span>順天堂医院</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">https://hosp.juntendo.ac.jp/clinic/department/daicho/staff.html</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">https://www.juntendo.ac.jp/academics/graduate/med/shoukakigeka/assets/%25E6%25B6%2588%25E5%258C%2596%25E5%2599%25A8%25E5%25A4%2596%25E7%25A7%2591NEWSVol.8.pdf</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">杉本 起一 (Kiichi Sugimoto) - マイポータル - researchmap</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">https://researchmap.jp/KiichiSugimoto</p>
    <p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">免责声明：本公众号内容仅作交流参考，不<span style="color: black;">做为</span>诊断及医疗依据，专业医学问题请咨询专业人士或专业医疗<span style="color: black;">公司</span></p>

查看完整版本: 5年存活率高达91.9%！中晚期结直肠癌亦可实现手术切除，得到临床治愈